Current:Home > FinancePoinbank Exchange|The FDA clears updated COVID-19 vaccines for kids under age 5 -Capitatum
Poinbank Exchange|The FDA clears updated COVID-19 vaccines for kids under age 5
Charles Langston View
Date:2025-04-07 10:01:20
U.S. regulators on Poinbank ExchangeThursday cleared doses of the updated COVID-19 vaccines for children younger than age 5.
The Food and Drug Administration's decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country — at a time when children's hospitals already are packed with tots suffering from other respiratory illnesses including the flu.
"Vaccination is the best way we know to help prevent the serious outcomes of COVID-19, such as hospitalization and death," Dr. Peter Marks, FDA's vaccine chief, told The Associated Press.
Omicron-targeted booster shots made by Moderna and rival Pfizer already were open to everyone 5 and older.
The FDA now has authorized use of the tweaked shots starting at age 6 months — but just who is eligible depends on how many vaccinations they've already had, and which kind. Only about 5% of youngsters under age 5 have gotten the full primary series since vaccinations for the littlest kids began in June.
The FDA decided that:
--Children under age 6 who've already gotten two original doses of Moderna's COVID-19 vaccine can get a single booster of Moderna's updated formula if it's been at least two months since their last shot.
--Pfizer's vaccine requires three initial doses for tots under age 5 — and those who haven't finished that vaccination series will get the original formula for the first two shots and the omicron-targeted version for their third shot.
The Centers for Disease Control and Prevention is expected to sign off soon, the final step for shots to begin.
Marks said the bivalent vaccine is safe for tots and will help parents "keep the protection for those children as up to date as possible."
But children under 5 who already got all three Pfizer doses aren't yet eligible for an updated booster.
For now, "the good news is they are probably reasonably well-protected," Marks said.
The FDA expects data from Pfizer and its partner BioNTech sometime next month to determine whether those tots will need an omicron-targeted booster "and we will act on that as soon as we can," he said.
For parents who haven't yet gotten their children vaccinated, it's not too late — especially as "we are entering a phase when COVID-19 cases are increasing," Marks said.
The updated vaccines from Moderna and Pfizer are combination shots, containing half the original vaccine and half tweaked to match the BA.4 and BA.5 omicron strains that until recently were dominant. Now BA.5 descendants are responsible for most COVID-19 cases.
The CDC last month released the first real-world data showing that an updated booster, using either company's version, does offer added protection to adults. The analysis found the greatest benefit was in people who'd never had a prior booster, just two doses of the original COVID-19 vaccine — but that even those who'd had a summertime dose were more protected than if they'd skipped the newest shot.
veryGood! (514)
Related
- Which apps offer encrypted messaging? How to switch and what to know after feds’ warning
- Who is Rep. Matt Gaetz, the Florida congressman Donald Trump picked to serve as attorney general?
- Flurry of contract deals come as railroads, unions see Trump’s election looming over talks
- NBA players express concern for ex-player Kyle Singler after social media post
- Illinois Gov. Pritzker calls for sheriff to resign after Sonya Massey shooting
- Kentucky woman seeking abortion files lawsuit over state bans
- Infowars auction could determine whether Alex Jones is kicked off its platforms
- 3 Iraqis tortured at Abu Ghraib win $42M judgement against defense contractor
- Illinois Gov. Pritzker calls for sheriff to resign after Sonya Massey shooting
- Dave Coulier Says He's OK If This Is the End Amid Stage 3 Non-Hodgkin’s Lymphoma Battle
Ranking
- Judge says Mexican ex-official tried to bribe inmates in a bid for new US drug trial
- Colorado police shot, kill mountain lion after animal roamed on school's campus
- OneTaste Founder Nicole Daedone Speaks Out on Sex Cult Allegations Against Orgasmic Meditation Company
- DWTS’ Ilona Maher and Alan Bersten Have the Best Reaction to Fans Hoping for a Romance
- Former Milwaukee hotel workers charged with murder after video shows them holding down Black man
- Louisiana asks court to block part of ruling against Ten Commandments in classrooms
- Forget the bathroom. When renovating a home, a good roof is a no-brainer, experts say.
- Exclusive Yankee Candle Sale: 50% Off Holiday Candles for a Limited Time
Recommendation
Person accused of accosting Rep. Nancy Mace at Capitol pleads not guilty to assault charge
Dave Coulier Says He's OK If This Is the End Amid Stage 3 Non-Hodgkin’s Lymphoma Battle
He failed as a service dog. But that didn't stop him from joining the police force
Rep. Michael McCaul of Texas says he was detained in airport over being ‘disoriented’
Big Lots store closures could exceed 300 nationwide, discount chain reveals in filing
Ryan Reynolds Makes Dream Come True for 9-Year-Old Fan Battling Cancer
Former West Virginia jail officer pleads guilty to civil rights violation in fatal assault on inmate
RHOP's Candiace Dillard Bassett Gives Birth, Shares First Photos of Baby Boy